Creative Touch Permanent Makeup and Aesthetics

Polyunsaturated fatty acids (PUFAs) are characterised by two or more double bonds in their carbon chain. The term covers two biologically distinct families: omega-3 fatty acids, defined by a double bond at the third carbon from the methyl end, and omega-6 fatty acids, defined by a double bond at the sixth carbon. Both families include essential members – alpha-linolenic acid (ALA) in the omega-3 family and linoleic acid (LA) in the omega-6 family – that the body cannot synthesise and must obtain from diet. Both play active roles in skin biology well beyond their reputation as general “healthy fats.” ^[1]

The Omega-3 / Omega-6 Distinction

The omega-3 and omega-6 families do not behave the same way, and understanding the distinction matters for how dietary advice and topical recommendations are framed. Omega-3 fatty acids – particularly EPA and DHA – are precursors to anti-inflammatory eicosanoids and directly compete with arachidonic acid (AA) for incorporation into cell membrane phospholipids, moderating the inflammatory response. Omega-6 fatty acids include members with opposing roles: linoleic acid (LA) is structural in the stratum corneum, gamma-linolenic acid (GLA) and its metabolite DGLA generate anti-inflammatory prostaglandins, whilst AA drives the pro-inflammatory COX and LOX eicosanoid pathways. Treating PUFAs as a single category – either uniformly beneficial or uniformly inflammatory – collapses distinctions that are clinically meaningful.

A critical layer of this complexity is the competitive relationship between the two families at the enzyme level. Omega-3 and omega-6 fatty acids share the same delta-6 desaturase enzyme for their respective elongation pathways – meaning the dietary ratio of omega-6 to omega-3 intake directly determines which family’s metabolites predominate in tissue. When omega-6 intake is high relative to omega-3, delta-6 desaturase is preferentially occupied by omega-6 substrates, favouring AA production and the pro-inflammatory eicosanoid cascade over the EPA/ DHA-derived anti-inflammatory pathway. Estimated omega-6 to omega-3 ratios in modern Western diets have been reported at 15:1 to 16.7:1, compared to estimated ancestral ratios of approximately 1:1 – a shift that has direct consequences for the chronic inflammatory background in which skin conditions develop and persist. ^[4] The absolute intake of either family therefore matters less than their ratio – a nuance that population-level dietary recommendations based on minimum adequacy thresholds do not fully address.

Oxidative Vulnerability and Skin Damage

One shared characteristic of all PUFAs is oxidative vulnerability. The bis-allylic hydrogen atoms at double bond positions are susceptible to abstraction by reactive oxygen species, generating lipid peroxidation products including reactive aldehydes – most significantly 4-hydroxynonenal (4-HNE), produced specifically from omega-6 fatty acid oxidation via the 15-lipoxygenase-2 pathway expressed in human epidermis. This is relevant both to dietary fat quality and to topical formulation stability: oils high in polyunsaturated fatty acids oxidise more readily than those dominated by saturated or monounsaturated fats, and the oxidation products generated have established mechanistic links to skin damage through two distinct pathways. ^[2]

The first pathway is structural protein damage. Larroque-Cardoso et al. (2015) demonstrated in UV-A exposed mice that 4-HNE forms covalent adducts with elastin – the protein responsible for skin recoil and elasticity – producing the hallmark features of photoaging including elastotic material deposition and structural disorganisation. The critical finding was that carnosine, a carbonyl scavenger that neutralises 4-HNE, completely reversed both the photoaging features and the adduct formation – establishing causation rather than correlation. ^[3] The second pathway is cellular senescence. Swiader et al. (2021) demonstrated that 4-HNE exposure induces fibroblast senescence through DNA damage response activation and SIRT1 downregulation; senescent fibroblasts accumulate in aged skin and drive tissue degradation through the senescence-associated secretory phenotype (SASP), a pattern of MMP and inflammatory cytokine secretion that degrades the surrounding extracellular matrix. ^[5] Importantly, linoleic acid hydroperoxide – a primary LA oxidation product – has been directly detected in sebum from healthy human volunteers under normal ambient conditions, confirming that oxidation is not a pathological exception but an inherent consequence of having oxidisable substrate in tissue continuously exposed to oxygen and UV radiation. ^[2]

Skin Biology: Three Areas of Relevance

In skin biology, PUFAs are relevant across three areas. First, the structural lipid composition of the stratum corneum: linoleic acid occupies the specific acylceramide position in Ceramide EOS that anchors the lamellar bilayer to the cornified envelope – a non-substitutable structural role covered in detail in the Linoleic Acid and Ceramide Synthesis entities. Second, the inflammatory and anti-inflammatory signalling cascades that govern conditions from atopic dermatitis to wound healing: the omega-3/omega-6 competitive eicosanoid balance determines the inflammatory tone of the skin, and several randomised controlled trials have demonstrated measurable benefit from omega-3 supplementation in atopic dermatitis and psoriasis, with reductions in TEWL, pruritus, and inflammatory lesion counts – the clinical evidence for which is examined in the Omega-3 Fatty Acids entity. Third, the oxidation chemistry occurring in sebum and topical formulations at the skin surface, where the inherent reactivity of PUFA double bonds generates damage products under the ambient UV and oxygen exposure that is unavoidable in skin.